Hypersensitivity to linezolid or any of the other components of Linezolid.
Monoamine Oxidase lnhibitors: Linezolid should not be used in patients taking any medicinal product which inhibits monoamine oxidases A or B (eg, phenelzine, isocarboxazid) or within 2 weeks of taking any such medicinal product.
Potential Interactions Producing Elevation of Blood Pressure: Unless patients are monitored for potential increases in blood pressure, linezolid should not be administered to patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis and/or patients taking any of the following types of medications: Directly and indirectly acting sympathomimetic agents (eg, pseudoephedrine), vasopressive agents (eg, epinephrine, norepinephrine), dopaminergic agents (eg, dopamine, dobutamine).
Potential Serotonergic Interactions: Unless patients are carefully observed for signs and/or symptoms of serotonin syndrome, linezolid should not be administered to patients with carcinoid syndrome and/or patients taking any of the following medications: Serotonin re-uptake inhibitors, bicyclic antidepressants, serotonin 5-HT1 receptor agonists (triptans), meperidine or buspirone.
Other Services
Country
Account